News
Aurora Spine Corporation Schedules Conference Call to Update Investors and Discuss Financial Results for the First Quarter of Fiscal Year 2024
Aurora Spine Corporation
CARLSBAD, Calif., May 13, 2024 (GLOBE NEWSWIRE) — Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), designer and manufacturer of innovative medical devices that improve outcomes Spinal Surgery Company, announced today that it has scheduled a conference call to update investors and discuss financial results for the fiscal 2024 first quarter ending March 31, 2024. Management will hold the conference call on Tuesday, May 14, 2024. 2024, 11am ET.
Q1 FY 2024 Conference Call Details
Date and time: Tuesday, May 14, 2024 at 11am ET / 8am PT
Call information: Interested parties may access the conference call by calling (844) 861-5497 or (412) 317-5794.
Webcast: Interested parties will be able to access the conference call via live webcast, available at the following link: https://app.webinar.net/JbqanyRDeyx.
Repetition: A replay of the conference call will be available through May 21, 2024, by calling (877) 344-7529 or (412) 317-0088, replay access code 9427446. Additionally, a replay of the webcast will be available at https://app.webinar.net/JbqanyRDeyx for 90 days.
About Aurora Spine
Aurora Spine is focused on bringing new solutions to the spinal implant market through a series of innovative, minimally invasive and regenerative spinal implant technologies. Additional information can be accessed at www.aurora-spine.com.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Forward-Looking Statements
This press release contains forward-looking information that involves substantial known and unknown risks and uncertainties, most of which are beyond Aurora Spine’s control, including, without limitation, those listed under “Risk Factors” and “Cautionary Statement Regarding Forward-Looking Information ” in Aurora Spine’s final prospectus (collectively, “forward-looking information”). Forward-looking information contained in this press release includes information regarding the proposed use and success of the Company’s products in surgical procedures. Aurora Spine cautions investors in Aurora Spine securities about important factors that could cause Aurora Spine’s actual results to differ materially from those projected in any forward-looking statements included in this press release. Any statements that express or involve discussions of expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and may be forward-looking and may involve estimates, assumptions and uncertainties that may cause actual results or results. differ unilaterally from those expressed in such forward-looking statements. No assurance can be given that the expectations set forth herein will prove to be correct and, accordingly, potential investors should not place undue reliance on these forward-looking statements. These statements speak only as of the date of this press release and Aurora Spine undertakes no obligation to update or revise them to reflect new events or circumstances.
The story continues
Contact:
Aurora Spine Corporation
Trent Northcutt
President and CEO
(760) 424-2004
Chad Clouse
CFO
(760) 424-2004
